Aquestive Therapeutics, Inc. announced changes in its leadership, including new directors and officer appointments.

Sep 29, 2026, 7:25 AM ETNew bossRead the original at SEC EDGAR

Neutral

AQST adds an independent director, bringing its board to 8 members, 7 of them independent. The director receives 57,000 stock options, but the filing reports no change to the company's business or results.

AQST · Aquestive Therapeutics, Inc.

AI read · Neutral

The AI's read

This adds an independent voice to the board, but the filing reports no change to the company's products, sales, or results. Daly will receive 57,000 stock options, which could add shares if exercised. The appointment does not show a change to AQST's business outlook.

Get alerts for AQST

Follow Aquestive Therapeutics, Inc. (AQST) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for AQST

Free on the App Store and Google Play, or on the web.